Business Segments · Depreciation
Neuroscience — Depreciation
Medtronic Neuroscience — Depreciation increased by 1.3% to $80.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.6%, from $73.00M to $80.00M. Over 2 years (FY 2022 to FY 2025), Neuroscience — Depreciation shows an upward trend with a 8.5% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026
How to read this metric
High depreciation relative to assets may indicate a need for future capital expenditure to replace aging equipment.
Detailed definition
This is the systematic allocation of the cost of tangible assets used by the Neuroscience segment over their useful live...
Peer comparison
Comparable to depreciation expense disclosures in segment-level reporting for capital-intensive industries.
Metric ID:
mdt_segment_neuroscience_depreciationHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $66.25M | $66.25M | $66.25M | $66.25M | $66.75M | $66.75M | $66.75M | $66.75M | $65.00M | $71.00M | $73.00M | $83.00M | $77.00M | $79.00M | $80.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.8% | +0.0% | +0.0% | +0.0% | -2.6% | +9.2% | +2.8% | +13.7% | -7.2% | +2.6% | +1.3% |
| YoY Change | — | — | — | — | +0.8% | +0.8% | +0.8% | +0.8% | -2.6% | +6.4% | — | — | +18.5% | +11.3% | +9.6% |
Range$65.00M – $83.00M
CAGR+5.5%
Avg YoY Growth+5.1%
Median YoY Growth+0.8%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's neuroscience — depreciation?
- Medtronic (MDT) reported neuroscience — depreciation of $80.00M in Q1 2026.
- How has Medtronic's neuroscience — depreciation changed year-over-year?
- Medtronic's neuroscience — depreciation increased by 9.6% year-over-year, from $73.00M to $80.00M.
- What is the long-term trend for Medtronic's neuroscience — depreciation?
- Over 2 years (2022 to 2025), Medtronic's neuroscience — depreciation has grown at a 8.5% compound annual growth rate (CAGR), from $265.00M to $312.00M.
- What does neuroscience — depreciation mean?
- The non-cash expense representing the aging of equipment used in the neuroscience business.